Đang chuẩn bị liên kết để tải về tài liệu:
Comparison between clinical features and prognosis of malignancy- and nonmalignancy–associated pediatric hemophagocytic lymphohistiocytosis

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ

The differences between the clinical characteristics and survival time in malignancy- and nonmalignancy–associated secondary hemophagocytic lymphohistiocytosis (HLH) are unclear. Here, we describe the clinical characteristics, prognostic factors, and survival outcomes of malignancy-associated HLH compared to that of non-malignancy–associated HLH. | Comparison between clinical features and prognosis of malignancy- and nonmalignancy–associated pediatric hemophagocytic lymphohistiocytosis

TÀI LIỆU LIÊN QUAN

Genome comparison between clinical and environmental strains of Herbaspirillum seropedicae reveals a potential new emerging bacterium adapted to human hosts

Comparison between clinical features and prognosis of malignancy- and nonmalignancy–associated pediatric hemophagocytic lymphohistiocytosis

Comparison between the effects of progesterone versus corticosteroid local injections in mild and moderate carpal tunnel syndrome: A randomized clinical trial

báo cáo khoa học: " Comparison of KRAS and EGFR gene status between primary non-small cell lung cancer and local lymph node metastases: implications for clinical practice"

Levels of evidence: A comparison between top medical journals and general pediatric journals

Predicting clinical outcomes in chordoma patients receiving immunotherapy: A comparison between volumetric segmentation and RECIST

Assessing health status in COPD. A head-to-head comparison between the COPD assessment test (CAT) and the clinical COPD questionnaire (CCQ)

Clinical characteristics and disease outcomes in ER+ breast cancer: A comparison between HER2+ patients treated with trastuzumab and HER2- patients

Comparison of morbidity and mortality of very low birth weight infants in a Central Hospital in Johannesburg between 2006/2007 and 2013

Comparison of clinical outcomes between luminal invasive ductal carcinoma and luminal invasive lobular carcinoma